The H+-linked monocarboxylate transporter (MCT1/SLC16A1): A potential therapeutic target for high-risk neuroblastoma

Molecular Pharmacology

Volumn 70, Issue 6, 2006, Pages 2108-2115

  Fang, Jun ^a   Quinones, Quintin J ^a   Holman, Trevor L ^a   Morowitz, Michael J ^b   Wang, Qun ^a,b   Zhao, Huaqing ^b   Sivo, Frank ^a   Maris, John M ^b   Wahl, Miriam L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; LONIDAMINE; MONOCARBOXYLATE TRANSPORTER; PROTEIN MCT1; PROTEIN SLC16A1; UNCLASSIFIED DRUG;

ACIDIFICATION; ADULT; ARTICLE; CELL DEATH; CELL METABOLISM; CELL VIABILITY; DOSE RESPONSE; HUMAN; HUMAN CELL; NEUROBLASTOMA; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; MONOCARBOXYLIC ACID TRANSPORTERS; NEUROBLASTOMA; PROTONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYMPORTERS;

EID: 33751091519     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.026245     Document Type: Article

References (40)

1. Balazs M, Adam Z, Treszi A, Begany A, Hunyadi J, and Adany R (2001) Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry 46:222-232.
2. 13C nuclear magnetic resonance studies. Cancer Res 55:2814-2821.
3. Ben-Yoseph O, Lyons JC, Song CW, and Ross BD (1998) Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification. J Neuro-Oncology 36:149-157.
4. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, and Mueller-Klieser W (2001) Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51:349-353.
5. Brodeur GM (2002) Commentary on Kaneko et al.: Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification. J Pediatr Hematol Oncol 24:608-609.
6. Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203-216.
7. Dang CV, Resar LMS, Emison E, Kim SH, Li Q, Prescott JE, Wonsey D, and Zeller K (1999) Function of the c-Myc oncogenic transcription factor. Exp Cell Res 253:63-77.
8. Di Cosimo S, Ferretti G, Papaldo P, Carlini P, Fabi A, and Cognetti F (2003) Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors. Drugs Today (Barc) 39:157-174.
9. Dimmer K-S, Friedrich B, Lang F, Deitmer JW, and Broer S (2000) The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochemistry J 350:219-227.
10. Eastman A (1995) Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis. Semin Cancer Biol 6:45-52.
11. Floridi A, Paggi MG, D'Altri S, DeMartino C, Marcante ML, Silvestrini B, and Caputo A (1981) Effect of lonidamine on energy metabolism in Ehrlich ascites tumor cells. Cancer Res 41:4661-4666.
12. Halestrap AP and Meredith D (2004) The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflueg Arch Eur J Physiol 447:619-628.
13. Kim-Garcia C, Brown MS, Pathak RK, and Goldstein JL (1995) cDNA cloning of MCT2, a second monocarboxylate transporter expressed in different cells than MCT1. J Biol Chem 270:1843-1849.
14. Koslowski M, Tureci O, Bell C, Krause P, Lehr HA, Brunner J, Seitz G, Nestle FO, Huber C, and Sahin U (2002) Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. Cancer Res 62:6750-6755.
15. Kushner BH, LaQuaglia MP, Modak S, and Cheung NK (2003) Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCN-amplification. Med Pediatr Oncol 41:80-82.
16. Lin R-Y, Vera JC, Chaganti RSK, and Golde DW (1998) Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J Biol Chem 273:28959-28965.
17. Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, and Brodeur GM (1991) Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 9:581-591.
18. Mardor Y, Kaplan O, Sterin M, Ruiz-Cabello J, Ash E, Roth Y, Ringel I, and Cohen JS (2000) Noninvasive real-time monitoring of intracellular cancer cell metabolism and response to lonidamine treatment using diffusion weighted proton magnetic resonance spectroscopy. Cancer Res 60:5179-5186.
19. Maris JM (2005) The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr 17:7-13.
20. Mathupala SP, Parajuli P, and Sloan AE (2004) Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study. Neurosurgery 55:1410-1419.
21. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, et al. (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341:1165-1173.
22. Miyato Y and Ando K (2004) Apoptosis of human melanoma cells by a combination of lonidamine and radiation. J Radiat Res (Tokyo) 45:189-194.
23. Oudard S, Carpentier A, Banu E, Fauchon F, Celerier D, Poupon MF, Dutrillaux B, Andrieu JM, and Delattre JY (2003) Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme. J Neurooncol 63:81-86.
24. Owen CS, Pooler PM, Wahl ML, Bobyock SB, Coss RA, and Leeper DB (1997) Altered proton extrusion in cells adapted to growth at low extracellular pH. J Cell Physiol 173:397-405.
25. Paggi MG, Fanciulli M, Perrotti N, Floridi A, Zeuli M, Silvestrini B, and Caputo A (1988) The role of mitochondrial hexokinase in neoplastic phenotype and its sensitivity to lonidamine. Ann NY Acad Sci 551:358-360.
26. Pratesi G, De Cesare M, and Zunino F (1996) Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft. Cancer Chemother Pharmacol 38:123-128.
27. Pulselli R, Amadio L, Fanciulli M, and Floridi A (1996) Effect of lonidamine on the mitochondrial potential in situ Ehrlich ascites tumor cells. Anticancer Res 16:419-423.
28. Scarantino CW, Newton RE, Paggiarino DA, and DeGregorio M (1991) Lonidamine in head and neck cancer: an overview. Semin Oncol 2 Suppl 4:28-32.
29. Skoyum R, Eide K, Berg K, and Rofstad EK (1997) Energy metabolism in human melanoma cells under hypoxic and acidic conditions. Br J Cancer 76:421-428.
30. Sladowski D, Steer SJ, Clothier RH, and Balls M (1993) An improved MTT assay. J Immunol Methods 157:203-207.
31. Stryker JA and Gerweck LE (1988) Lonidamine-induced, pH dependent inhibition of cellular oxygen utilization. Rad Res 113:356-361.
32. Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, Cohn SL, Cheung NK, Seeger RC, Evans AE, and Ikegaki N (2006) The MYCN enigma: significance of MYCN expression in neuroblastoma. Cancer Res 66:2826-2833.
33. Wahl ML, Bobyock SB, Leeper DB, and Owen CS (1997) Effects of 42°C hyperthermia on intracellular pH in ovarian carcinoma cells during acute acidification or chronic exposure to low extracellular pH. Int J Radiat Oncol Biol Phys 39:205-212.
34. Wahl ML, Owen JA, R. B., Herlands RA, Nogami SS, Rodeck U, Berd D, Leeper DB, and Owen CS (2002) Regulation of intracellular pH in human melanoma: potential therapeutic implications. Mol Cancer Ther 1:617-628.
35. Wahl ML, Pooler PM, Briand P, Leeper DB, and Owen CS (2000) Intracellular pH regulation in a nonmalignant and a derived malignant human breast cell line. J Cell Physiol 183:373-380.
36. Walenta S, Salameh A, Lyng H, Evensen JF, Mitze M, Rofstad EK, and Mueller-Klieser W (1997) Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol 150:409-415.
37. Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D, Seiser E, Jagannathan J, Shusterman S, Bansal M, et al. (2006) Integrative genomics identifies distinct molecular classes of neuroblastoma and demonstrates that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res 66:6050-6062.
38. Warburg O (1930) The Metabolism of Tumours: Investigations from the Kaiser Wilhelm Institute for Biology, Dahlem, Berlin.
39. Wilson MC, Jackson VN, Heddle C, Price NT, Pilegaard H, Juel C, Bonen A, Montgomery I, Hutter OF, and Halestrap AP (1998) Lactic acid efflux from white skeletal muscle is catalyzed by the monocarboxylate transporter isoform MCT3. J Biol Chem 273:15920-15926.
40. Zhou R, Bansal N, Leeper DB, Pickup S, and Glickson JD (2001) Enhancement of hyperglycemia-induced acidification of human melanoma xenografts by inhibitors of respiration and ion transport. Acad Radiol 8:571-582.